Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion type Assertion NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_head.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion evidence source_evidence_literature NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion SIO_000772 1835747 NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion wasDerivedFrom befree-20140225 NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.
- NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion wasGeneratedBy ECO_0000203 NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.